Delivery Order SPE2DB22D3016-SPE2DB24FBCG7
Award Date
7/26/24
Potential Completion Date
8/16/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEKLURY (remdesivir) 100 mg vials. The contract, valued at $15,848.80, is a firm fixed-price delivery order that runs through March 11, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026, which serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,754.64, is for the delivery of the drug VEKLURY (Remdesivir) 100 mg vials. It is a firm fixed-price contract with a completion date of June 2, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $11,886.60. The contract is for the supply of VEKLURY (Remdesivir) 100 mg vials, a medication used to treat COVID-19. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg VEKLURY (remdesivir) vials. The contract has a ceiling value of $13,618.40 and an ultimate completion date of September 20, 2024. It is a firm-fixed-price contract and does not utilize any set-aside designations. AmerisourceBergen, through its Corporate Office Division, has been awarded numerous federal contracts and...
This is a delivery order award under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) valued at $30,112.72 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VEKLURY (remdesivir) 100 mg vials, a critical antiviral medication. The award has an ultimate completion date of April 4, 2025 and uses a firm fixed price pricing type. This order is part of a larger $999,999,999 IDC that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The total ceiling value of the contract is $3,169.76, with a period of performance through March 25, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,213.60 firm fixed-price delivery order is for the supply of VEKLURY (Remdesivir) 100 mg vials. The contract has a completion date of July 26, 2022 and does not include any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This contract is a delivery order awarded to Amerisourcebergen Drug Corporation's Corporate Office division by the Defense Logistics Agency (DLA) Troop Support Medical. The $13,618.40 fixed-price contract is for the delivery of VEKLURY (Remdesivir) 100 mg vials, a critical medication used in the treatment of COVID-19. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for providing a...
This is a $6,809.20 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of Veklury (Remdesivir) 100 mg vials, a pharmaceutical product used for the treatment of COVID-19. The contract is a firm-fixed-price arrangement with an ultimate completion date of October 17, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of VEKLURY (Remdesivir) 100 mg vials. The contract has a ceiling value of $8,511.50 and an ultimate completion date of September 24, 2024. The award is a firm fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other...